CardioGenics Holdings Inc. is focused on technology and products targeting the immunoassay segment of the In-Vitro Diagnostic testing market. The Company has developed the QL Care Analyzer, a point-of-care immuno-analyzer, which is capable of running approximately 200+immunoassay diagnostic tests, such as cardiovascular diagnostic tests. As part of its technology, the Company has also developed a method for silver coating paramagnetic microspheres (a fundamental platform component of immunoassay equipment), which improves instrument sensitivity to light.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

Quotes

Date	Price	Change	Volume

Delayed Quote OTC Markets

More quotes

Market Closed - OTC Markets 10:39:02 17/09/2026 pm IST			5-day change	1st Jan Change
0.000001 ^USD	-99.00%		0.00%	-

10/21/10	Cardiogenics Holdings Inc Announces A Record Date Change for Its Dividend Distribution	CI
04/21/04	CardioGenics Holdings Inc. Announces License Agreement	CI

Market Cap	4L 3L 3L 3L 5L 3.66Cr 5L 37.52L 14.51L 1.86Cr 14.36L 14.04L 5.95Cr	P/E 2014	-2.3x	P/E 2015	-2.17x
Enterprise Value	5L 5L 4L 4L 8L 5.16Cr 8L 52.89L 20.45L 2.62Cr 20.24L 19.79L 8.39Cr	EV / Sales 2014	-	EV / Sales 2015	-
Free-Float	97.49%	Yield 2014 *	-	Yield 2015	-

10/21/10	Cardiogenics Holdings Inc Announces A Record Date Change for Its Dividend Distribution	CI
04/21/04	CardioGenics Holdings Inc. Announces License Agreement	CI
02/15/02	CardioGenics Holdings Inc completed the acquisition of substantially all of the assets of Plasticap Inc.	CI
05/15/05	CardioGenics Holdings Inc entered into a non-binding letter of intent to acquire substantially all of the assets of Plasticap Inc.	CI
13/15/13	CardioGenics Holdings Inc. Appoints Karim Murabet as Director	CI
27/13/27	CardioGenics Holdings Inc Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2013	CI
21/13/21	CardioGenics Holdings Inc Announces Commencement of Beta-Site Testing	CI
05/13/05	CardioGenics Holdings Inc Announces Internal Review Board Approval for Beta-Site Testing	CI
03/13/03	CardioGenics Holdings Inc announced that it has received $0.66 million in funding.	CI
31/13/31	CardioGenics Holdings Inc announced that it expects to receive $1.5 million in funding.	CI
01/13/01	CardioGenics Holdings Inc. Announces Demise of Director, Alexander D. G. Reid	CI
27/13/27	CardioGenics Holdings Inc. announced that it expects to receive $1 million in funding.	CI
17/12/17	CardioGenics Holdings Inc has Changed its Ticker to CGNH from CGNHE	CI

29/21/29	UPDATED: CARDIOGENICS HOLDINGS INC. ANNOUNCES A RECORD DATE CHANGE FOR ITS DIVIDEND DISTRIBUTION	AQ
10/21/10	CARDIOGENICS : ANNOUNCES A RECORD DATE CHANGE FOR ITS DIVIDEND DISTRIBUTION	AQ
04/21/04	CARDIOGENICS : ANNOUNCES LICENSE AGREEMENT AND DIVIDEND DISTRIBUTION	AQ
05/15/05	CardioGenics : Enters Into Asset Purchase Agreement to Acquire All Assets of Ontario-Based Plasticap	MW
05/15/05	CardioGenics : Enters Into Binding Letter of Intent to Acquire Assets of Ontario-Based Plasticap	MW

CardioGenics Holdings Inc Share Price

Stocks

CGNH

US14160X2036

Medical Equipment, Supplies & Distribution

Valuation: CardioGenics Holdings Inc

Chart: CardioGenics Holdings Inc

Latest news: CardioGenics Holdings Inc

Press Releases: CardioGenics Holdings Inc

Quotes and Performance

Price Extremes

Managers and Directors: CardioGenics Holdings Inc

Diagnostic & Testing Substances

Financials

Company Profile

Quotes

1 week	0		0
1 month	0		0
Current year	0		0
1 year	0		0
3 years	0		0
5 years	0		0.05
10 years	0		0.29

Manager	Title	Age	Since
Yahia A. Gawad CEO	Chief Executive Officer	68	27/10/2009
James A. Essex DFI	Director of Finance/CFO	78	16/06/2010
Linda J. Sterling IRC	Investor Relations Contact	65	-

Director	Title	Age	Since
Yahia A. Gawad BRD	Director/Board Member	68	06/04/2011
Julian Neil Tabatznik CHM	Chairman	76	16/06/2010
Linda J. Sterling BRD	Director/Board Member	65	16/06/2010

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CARDIOGENICS HOLDINGS INC	-99.00%	0.00%	-	-	142
GUARDANT HEALTH, INC.	+4.69%	+15.14%	+220.16%	+520.05%	2.46TCr
BIOMÉRIEUX	-0.48%	+0.70%	-36.53%	-21.55%	974.24Cr
10X GENOMICS, INC.	+5.90%	+15.95%	+498.52%	+54.78%	1TCr
CARIS LIFE SCIENCES, INC.	+9.61%	+28.62%	-7.78%	-	873.78Cr
LANTHEUS HOLDINGS, INC.	+0.26%	+0.41%	+98.27%	+55.53%	657.95Cr
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	+0.22%	+1.87%	-29.50%	-24.49%	575Cr
DIASORIN S.P.A.	+1.30%	+3.61%	-3.12%	-17.22%	433.39Cr
ANDON HEALTH CO., LTD.	+0.95%	-3.17%	+53.60%	+64.65%	377.92Cr
AUTOBIO DIAGNOSTICS CO., LTD.	+0.78%	+0.09%	-21.43%	-30.67%	274.01Cr
Average	-7.58%	+6.80%	+85.80%	+75.13%	762.63Cr
Weighted average by Cap.	+3.51%	+10.76%	+138.89%	+198.86%

	2014	2015
Net sales	-	-
Net income	-26.8L -23.34L -22.09L -20.07L -37.5L -26Cr -37.68L -2.63Cr -1.02Cr -13Cr -1.01Cr -98.43L -42Cr	-19.16L -16.69L -15.8L -14.35L -26.81L -18Cr -26.95L -1.88Cr -72.76L -9.33Cr -71.99L -70.39L -30Cr
Net Debt	1L 1L 1L 99.04T 2L 1.27Cr 2L 12.98L 5L 64.36L 5L 5L 2.06Cr	2L 1L 1L 1L 2L 1.5Cr 2L 15.37L 6L 76.18L 6L 6L 2.44Cr